Literature DB >> 18750672

Treatment of small-cell lung cancer.

C W Taylor.   

Abstract

Entities:  

Year:  1989        PMID： 18750672      PMCID： PMC1026802     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  4 in total

1.  Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada.

Authors:  W K Evans; R Feld; N Murray; A Willan; P Coy; D Osoba; F A Shepherd; D A Clark; M Levitt; A MacDonald
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

2.  Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.

Authors:  M C Perry; W L Eaton; K J Propert; J H Ware; B Zimmer; A P Chahinian; A Skarin; R W Carey; H Kreisman; C Faulkner
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

3.  Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.

Authors:  R Feld; W K Evans; P Coy; I Hodson; A S MacDonald; D Osoba; D Payne; W Shelley; J L Pater
Journal:  J Clin Oncol       Date:  1987-09       Impact factor: 44.544

4.  Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

Authors:  L H Einhorn; J Crawford; R Birch; G Omura; D H Johnson; F A Greco
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.